Discovery of a kinome signature predicting sensitivity and resistance to RAF-MAPK pathway inhibitors in melanoma

被引：0
|
作者：
Hilhorst, Riet
Krayem, Mohammed
Van den Berg, Adrienne
Journe, Fabrice
Hovestad-Bijl, Liesbeth
Van den Hooven, Tim
de Wijn, Rik
Aftimos, Philippe
Ghanem, Ghanem
Ruijtenbeek, Rob
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-3163
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3163
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Proliferation arrest in B-Raf mutant melanoma cell lines upon MAPK pathway activation
    Houben, R.
    Becker, J. C.
    EXPERIMENTAL DERMATOLOGY, 2008, 17 (03) : 278 - 278
  • [42] Developments in the Space of New MAPK Pathway Inhibitors for BRAF-Mutant Melanoma
    Cohen, Justine, V
    Sullivan, Ryan J.
    CLINICAL CANCER RESEARCH, 2019, 25 (19) : 5735 - 5742
  • [43] Resistance to B-RAF inhibitor is mediated by reactivation of MAPK pathway by FGFR3/Ras signaling in B-RAF V600E mutant melanoma
    Yadav, Vipin
    Zhang, Xiaoyi
    Liu, Jiangang
    Estrem, Shawn
    Li, Shuyu Dan
    Gong, Xue-Qian
    Buchanan, Sean
    Henry, James R.
    Starling, James J.
    Peng, Sheng-Bin
    CLINICAL CANCER RESEARCH, 2012, 18 (10)
  • [44] The MAPK Pathway Regulates Intrinsic Resistance to BET Inhibitors in Colorectal Cancer
    Ma, Yufang
    Wang, Lihong
    Neitzel, Leif R.
    Loganathan, Sudan N.
    Tang, Nan
    Qin, Lili
    Crispi, Emily E.
    Guo, Yan
    Knapp, Stefan
    Beauchamp, R. Daniel
    Lee, Ethan
    Wang, Jialiang
    CLINICAL CANCER RESEARCH, 2017, 23 (08) : 2027 - 2037
  • [45] Discovery of potent Pan-Raf inhibitors with increased solubility to overcome drug resistance
    Wang, Lu
    Zhang, Yanmin
    Zhang, Qing
    Zhu, Gaoyuan
    Zhang, Zhimin
    Duan, Chunqi
    Lu, Tao
    Tang, Weifang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 163 : 243 - 255
  • [46] Modeling acquired resistance to MAPK pathway inhibitors in KRAS mutant tumors
    Liu, Bonnie
    O'Brien, Carol
    Song, Kyung
    Spoerke, Jill
    Moffat, John
    Seshagiri, Somasekar
    Friedman, Lori S.
    Belvin, Marcia
    Lackner, Mark
    Hatzivassiliou, Georgia
    CANCER RESEARCH, 2011, 71
  • [47] MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors
    Motti, Maria Letizia
    Minopoli, Michele
    Di Carluccio, Gioconda
    Ascierto, Paolo Antonio
    Carriero, Maria Vincenza
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12) : 1 - 16
  • [48] Targeting p63 Upregulation Abrogates Resistance to MAPK Inhibitors in Melanoma
    Patel, Ankit
    Garcia, Lucia Fraile
    Mannella, Viviana
    Gammon, Luke
    Borg, Tiffanie-Marie
    Maffucci, Tania
    Scatolini, Maria
    Chiorino, Giovanna
    Vergani, Elisabetta
    Rodolfo, Monica
    Maurichi, Andrea
    Posch, Christian
    Matin, Rubeta N.
    Harwood, Catherine A.
    Bergamaschi, Daniele
    CANCER RESEARCH, 2020, 80 (12) : 2676 - 2688
  • [49] Resistance to BET inhibitors involves the β-catenin pathway in uveal melanoma
    Ambrosini, Grazia
    Tycko, Benjamin
    Do, Chaterine
    Schwartz, Gary K.
    CANCER RESEARCH, 2017, 77
  • [50] Tumor heterogeneity and plasticity as elusive drivers for resistance to MAPK pathway inhibition in melanoma
    A Roesch
    Oncogene, 2015, 34 : 2951 - 2957
12345